Papers
2
Total Citations
81
H-Index
2
About
Dr. Chul Won Choi is a leading radiation oncologist whose research centers on advanced stereotactic radiotherapy techniques for challenging cancers. His work has significantly advanced the application of robotic radiosurgery and volumetric modulated arc therapy, particularly for head and neck and liver malignancies. In a landmark 2009 study (55 citations), Dr. Choi demonstrated the efficacy of robotic system-based fractionated stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma, offering a critical salvage option for patients with limited alternatives. He further made pivotal contributions to hepatocellular carcinoma (HCC) treatment through a 2015 dosimetric comparison (26 citations) that systematically evaluated CyberKnife robotic SBRT against RapidArc volumetric modulated arc therapy. This work provided essential guidance for optimizing treatment planning and delivery in HCC, directly impacting clinical practice. Dr. Choi’s research bridges the gap between technological innovation and patient outcomes, establishing him as a key figure in stereotactic body radiation therapy. His comparative analyses help clinicians select the most effective radiation modality for complex tumor sites, ultimately improving therapeutic ratios and expanding treatment possibilities for patients with recurrent or difficult-to-treat cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2